FIELD: medicine.
SUBSTANCE: invention refers to medicine and can be used for treating endothelial dysfunction in diabetes mellitus. That is ensured by the method of general corrective action on the body. An experimental animal who underwent simulated diabetes mellitus is administered parenterally the Deltalicin preparation dissolved in physiologic sodium chloride solution in dose of 100.0 mcg/kg of body weight, ten times every 24 hours between injections starting from the third day after simulating diabetes mellitus.
EFFECT: invention provides treating endothelial dysfunction in diabetes mellitus, which enables to prevent the development of complications of diabetes, life-threatening patient.
1 cl, 4 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION IN CARBOHYDRATE METABOLISM DISORDERS ACCOMPANIED BY END-STAGE INSULIN DEFICIENCY | 2020 |
|
RU2751414C1 |
| SOLUTION WITH OF ENDOTHELIOPROTECTIVE POTENCY | 2017 |
|
RU2643605C1 |
| DIAGNOSTIC TECHNIQUE AND METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION IN VASCULAR COMPLICATIONS OF ALLOXAN DIABETES IN EXPERIMENT | 2010 |
|
RU2455702C1 |
| HERBAL MEDICINAL PRODUCT HAVING ENDOTHELIOPROTECTIVE ACTIVITY | 2014 |
|
RU2561064C1 |
| METHOD FOR CORRECTION OF OXIDATIVE STRESS AND NO PRODUCING ENDOTHELIAL DYSFUNCTION ACCOMPANYING VASCULAR COMPLICATIONS OF DIABETES MELLITUS IN EXPERIMENT | 2013 |
|
RU2521279C1 |
| DIAGNOSTIC TECHNIQUE FOR ENDOTHELIAL DYSFUNCTION IN PREGNANT WOMEN | 2020 |
|
RU2743851C1 |
| METHOD OF ESTIMATING FUNCTIONAL STATUS OF ENDOTHELIUM IN PATIENT WITH ARTERIAL HYPERTENSION AND ITS CEREBRAL COMPLICATIONS | 2008 |
|
RU2380705C1 |
| COMPOSITION POSSESSING ENDOTHELIAL PROTECTIVE, VASODILATING AND ANGIOPROTECTIVE EFFECT | 2011 |
|
RU2464019C1 |
| METHOD OF REDUCING INCREASE ENDOTHELIN I PRODUCTION IN CONDITIONS OF STRESS | 2009 |
|
RU2394612C1 |
| METHOD OF CORRECTING ENDOTHELIAL DYSFUNCTION WITH AZITHROMYCIN IN MODELING OF CHRONIC GRAM-POSITIVE SEPSIS | 2009 |
|
RU2400826C1 |
